Skip to main content

Keenova Therapeutics plc

MNKTQDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001567892

Keenova Therapeutics plc was delisted in 2023; its insiders filed their last Form 4 on Jul 23, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Keenova Therapeutics plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Keenova Therapeutics plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Keenova Therapeutics plc
NameTitleLast reported holdingLast filingFilings, past year
Williamson Susan AnnEVP & Chief Compliance Officer1,460Jul 23, 20263
Basso TracyEVP & CHRO1,542Jul 23, 20263
Stouch Cheryl AnnEVP & Chief Info Officer1,440Jul 23, 20263
Langlois Sophia D.Director2,191Jul 17, 20263
Yoskowitz Marc JDirector3,541Jul 17, 20264
Hirsch ScottDirector2,521Jul 17, 20263
Zinman JonDirector12,913IndirectJul 17, 20264
Efron PaulDirector11,220Jul 17, 20263
Donato Leslie EDirector2,066Jul 17, 20263
Dorton KatinaDirector7,387Jul 17, 20264
Bisaro PaulDirector6,244Jul 17, 20264
Mule Edward A10% Owner6,035,214May 21, 20266
Silver Point Capital L.P.10% Owner6,035,214May 21, 20266
O'Shea Robert J10% Owner6,035,214May 21, 20266
Olafsson Sigurdur OPresident and CEO31,718Feb 26, 20262
Stamoulis ChristianaPresident and CFO17,828Feb 26, 20263
Nielsen HenrietteEVP & Chief Transformation OFC7,538Feb 26, 20262
Tyndall Mark AnthonyEVP & CLO and Corp Sec8,167Feb 26, 20262
French LisaEVP & Chief Commercial Officer8,390Feb 26, 20262
ONeill Hugh PaulEVP, Chief Operations Officer1,802Feb 26, 20262
Honczarenko MarekEVP, Chief Scientific Officer–Feb 26, 20261
Goldentree Asset Management LP10% Owner7,979,827IndirectFeb 12, 20261
Tananbaum Steven A.10% Owner7,979,827IndirectFeb 12, 20261
GoldenTree Asset Management LLC10% Owner7,979,827IndirectFeb 12, 20261
Welch Stephen AndrewEVP & Head of Spec Generics3,631Nov 12, 20251
Wheeler WesleyDirector10,053Aug 4, 20250
Richardson Peter CEVP & Chief Scientific Officer3,419Aug 4, 20250
Reasons Bryan M.EVP & CFO5,114Aug 4, 20250
Stetson David J.Director11,578Aug 4, 20250
Bradley Mark T.EVP, Chief Integration Officer4,294Aug 4, 20250
Hussain AbbasDirector9,783Aug 4, 20250
Harrold KassieEVP & Chief Compliance Officer863Jan 2, 20250
Goodson Jason DanielEVP & Chief Strategy Officer3,750Jan 2, 20250
Bracebridge Capital, LLC10% Owner1,093,857IndirectNov 16, 20230
Olifant Luxco S.a r.l.10% Owner1,093,857IndirectNov 16, 20230
FFI III S.a r.l.10% Owner1,093,857IndirectNov 16, 20230
FYI S.a r.l.10% Owner1,093,857IndirectNov 16, 20230
Goldman Neal PDirector0Nov 16, 20230
Sulat James RDirector0Nov 16, 20230
Myers Woodrow A JrDirector0Nov 16, 20230
Ling KarenDirector0Nov 16, 20230
Silbermann Susan MicheleDirector0Nov 16, 20230
El-Dada Riad HusseinDirector0Nov 16, 20230
Celentano Daniel ArthurDirector0Nov 16, 20230
Youngblood Dr KneelandDirector–Jun 21, 20220
Watkins Ian JSee Remarks–Jun 21, 20220
Carlucci David RDirector–Jun 21, 20220
Reed Joann ADirector0Jun 21, 20220
Carroll J MartinDirector–Jun 21, 20220
Casey Mark JEVP & Chief Legal Officer0Jun 21, 20220

Showing the 50 most recent filers.

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 21, 2026 (view filing)8:59 PM ETMay 19-202 daysMule Edward A and 2 others10% OwnerPPurchase+397.5K$90.50+$36.0M+7.1%6.04M after2 lots
Apr 17, 2026 (view filing)5:23 PM ETApr 15-172 daysMule Edward A and 2 others10% OwnerPPurchase+685.0K$89.70+$61.4M+13.8%5.64M after2 lots
Jan 9, 2026 (view filing)5:26 PM ETJan 72 daysMule Edward A and 2 others10% OwnerPPurchase+250.0K$92.25+$23.1M+5.3%4.95M after
Dec 10, 2025 (view filing)6:14 PM ETDec 82 daysMule Edward A and 2 others10% OwnerPPurchase+131.0K$88.75+$11.6M+2.9%4.70M after
Nov 19, 2025 (view filing)6:39 PM ETNov 17-192 daysMule Edward A and 2 others10% OwnerPPurchase+68.0K$88.88+$6.04M+1.5%4.57M after2 lots
Nov 12, 2025 (view filing)8:16 PM ETNov 102 daysMule Edward A and 2 others10% OwnerPPurchase+290.0K$93.75+$27.2M+6.9%4.50M after
Aug 6, 2025 (view filing)7:45 PM ETAug 4-62 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+36.7K$88.21+$3.24M+0.5%7.95M after2 lots
Aug 4, 2025 (view filing)4:45 PM ETAug 13 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+50.0K$86.50+$4.33M+0.6%7.91M after
Jul 10, 2024 (view filing)4:30 PM ETJul 82 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+13.3K$54.50+$724.9K+0.4%3.33M after
Jun 18, 2024 (view filing)4:30 PM ETJun 144 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+275.0K$52.75+$14.5M+9.0%3.31M after
May 29, 2024 (view filing)4:33 PM ETMay 245 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+165.0K$50.00+$8.25M+5.7%3.04M after
May 13, 2024 (view filing)4:30 PM ETMay 94 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+475.0K$55.37+$26.3M+19.8%2.87M after2 lots
Mar 12, 2024 (view filing)4:30 PM ETMar 84 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+83.0K$43.63+$3.62M+3.6%2.40M after
Feb 20, 2024 (view filing)5:00 PM ETFeb 155 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+225.0K$38.25+$8.61M+10.8%2.32M after
Feb 6, 2024 (view filing)5:00 PM ETFeb 24 daysGoldentree Asset Management LP and 2 others10% OwnerPPurchase+20.0K$37.55+$751.0K+1.0%2.09M after
Dec 13, 2023 (view filing)4:17 PM ETDec 58 daysLateGoldentree Asset Management LP and 2 others10% OwnerPPurchase+75.0K$37.50+$2.81M+3.8%2.07M after
Mar 17, 2023 (view filing)Mar 161 dayGoodson Jason DanielEVP & Head of Corp DevelopmentPPurchase+1.13K$8.38+$9.50K+3.0%38.7K after2 lots
Mar 16, 2023 (view filing)Mar 14-152 daysSulat James RDirectorPPurchase+30.0K$8.48+$254.4K+57.1%82.6K after2 lots
Mar 16, 2023 (view filing)Mar 142 daysBisaro PaulDirectorPPurchase+5.00K$8.47+$42.4K+7.2%74.8K after
Mar 15, 2023 (view filing)Mar 132 daysWelch Stephen AndrewEVP & Head of Spec GenericsPPurchase+1.00K$8.48+$8.48K+2.7%38.5K after
Mar 15, 2023 (view filing)Mar 132 daysOlafsson Sigurdur OPresident and CEOPPurchase+3.00K$8.37+$25.1K+1.3%228.3K after
Mar 21, 2022 (view filing)4:23 PM ETMar 174 daysReed Joann ADirectorSSale−34.1K$0.1167−$3.98K−100.0%0 after2 lots
Aug 9, 2021 (view filing)9:10 AM ETAug 54 daysO'Neill Hugh M.EVP & Chief Comm & Ops OfcrSSale−2.10K$0.2558−$537.18−2.7%76.9K after
Aug 9, 2021 (view filing)9:09 AM ETAug 54 daysNorton David YDirectorSSale−5.08K$0.2626−$1.33K−100.0%0 after